- +1
Toby Dalton, Mark Hibbs, Nicole Grajewski, …
{
"authors": [
"Mark Hibbs"
],
"type": "legacyinthemedia",
"centerAffiliationAll": "dc",
"centers": [
"Carnegie Endowment for International Peace"
],
"collections": [
"China’s Foreign Relations"
],
"englishNewsletterAll": "ctw",
"nonEnglishNewsletterAll": "",
"primaryCenter": "Carnegie Endowment for International Peace",
"programAffiliation": "NPP",
"programs": [
"Nuclear Policy"
],
"projects": [],
"regions": [
"South Asia",
"Pakistan",
"East Asia",
"China"
],
"topics": [
"Nuclear Policy",
"Nuclear Energy",
"Security",
"Arms Control"
]
}Source: Getty
Moving Forward on China, Pakistan, and the NSG
Although Beijing agreed not to export nuclear reactors to Pakistan when it joined the Nuclear Suppliers Group in 2004, it is currently planning the construction of two reactors at the Chasma site in Pakistan.
Source: Arms Control Wonk

About the Author
Nonresident Senior Fellow, Nuclear Policy Program
Hibbs is a Germany-based nonresident senior fellow in Carnegie’s Nuclear Policy Program. His areas of expertise are nuclear verification and safeguards, multilateral nuclear trade policy, international nuclear cooperation, and nonproliferation arrangements.
- Dimming Prospects for U.S.-Russia Nonproliferation CooperationArticle
- What Comes After Russia’s Attack on a Ukrainian Nuclear Power Station?Commentary
Mark Hibbs
Recent Work
Carnegie does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.
More Work from Carnegie China
- Who Paid for China’s Last Debt Cleanup, and Who Will Pay for the Next?Commentary
China’s banking crisis in the 2000s was resolved by transferring the costs to households through financial repression—a decision that recapitalized the banks while exacerbating the structural imbalances that continue to shape the Chinese economy today.
Michael Pettis
- Caught in the Middle: Chinese Biotech Firms’ Divergent Responses to U.S. SanctionsCommentary
Chinese biotech companies have been on the receiving end of U.S. economic coercion. Yet their responses have differed significantly because firm and state interests are not uniformly aligned. For Washington, treating all Chinese tech firms the same, irrespective of their actual interests, risks pushing them farther into Beijing’s corner.
Xue Gong
- Are Data Centers the Solution to China’s Renewables Excess Capacity?Commentary
China’s latest energy plan explicitly calls for integrating data centers into the electricity system, particularly connecting them to green energy. It appears Beijing wants to use compute as a source of domestic demand to absorb renewables excess capacity.
Damien Ma
- Trump and Xi Are Angling for Three Years of StabilityCommentary
But their "principal to principal" model will only be as effective as the political strength of each leader back home.
Damien Ma
- China Sells Stability Amid American VolatilityCommentary
U.S. unpredictability has allowed China to capitalize on its positioning as the “responsible great power”. Paradoxically, the more China wins the perception game, the more likely expectations will rise for Beijing to deliver not just words but to demonstrate with its deeds.
Chong Ja Ian